Europe — EMA

Nubriveo (Brivaracetam)

Brivaracetam, the active ingredient in Nubriveo, is an antiepileptic presented as a oral medication for oral use. It treats certain seizure types in patients requiring adjunctive therapy.

Brivaracetam

Request sourcing

Pack/s

What is Brivaracetam?

Brivaracetam, the active ingredient in Nubriveo, is an antiepileptic presented as a oral medication for oral use. It treats certain seizure types in patients requiring adjunctive therapy.

GNH USA supplies Nubriveo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Brivaracetam used for?

Nubriveo is an antiepileptic drug that is used to manage the ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - Partial ... ... ... ... ...

What are the side effects of Brivaracetam?

Common .... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →